Ha habido 50 transacciones internas recientes registradas para Rocket Pharmaceuticals, Inc. (RCKT), incluyendo 24 compras y 23 ventas. El total de compras internas fue valorado en $5.77M y el total de ventas internas en $276.95K.
Internos destacados con actividad reciente incluyen Militello John, Wilson Martin, Shah Gaurav. Las transacciones internas pueden proporcionar información sobre cómo la dirección de la empresa ve la valoración y perspectivas futuras de la acción.
Operaciones de Insiders — RCKT
| Fecha |
Nombre |
Cargo |
Tipo de Transacción |
Acciones |
Precio Promedio |
Valor |
Acciones en Propiedad |
| 2026-02-18 |
Militello John |
See Remarks |
Venta Informativa |
1,157 |
$3.34 |
$3.86K |
91,019 |
| 2026-02-18 |
Wilson Martin |
General Counsel |
Venta Informativa |
1,376 |
$3.34 |
$4.59K |
682,000 |
| 2026-02-18 |
Shah Gaurav |
CEO |
Venta Informativa |
5,990 |
$3.34 |
$19.99K |
1,046,055 |
| 2026-02-13 |
Militello John |
See Remarks |
Venta Informativa |
3,726 |
$3.31 |
$12.34K |
92,176 |
| 2026-02-13 |
Wilson Martin |
General Counsel |
Venta Informativa |
12,253 |
$3.31 |
$40.58K |
683,376 |
| 2026-02-13 |
Shah Gaurav |
CEO |
Venta Informativa |
12,279 |
$3.31 |
$40.67K |
1,052,045 |
| 2026-02-11 |
Militello John |
See Remarks |
Concesión de RSU |
45,018 |
$3.24 |
$145.86K |
45,018 |
| 2026-02-11 |
Wilson Martin |
General Counsel |
Concesión de RSU |
468,187 |
$3.24 |
$1.52M |
468,187 |
| 2026-02-11 |
Shah Gaurav |
CEO |
Concesión de RSU |
870,648 |
$3.24 |
$2.82M |
870,648 |
| 2026-02-11 |
Rizvi Syed Ali-aamir |
Chief Medical Officer |
Concesión de RSU |
93,037 |
$3.24 |
$301.44K |
93,037 |
| 2026-02-11 |
Chaudhuri Sarbani |
See Remarks |
Concesión de RSU |
189,076 |
$3.24 |
$612.61K |
189,076 |
| 2026-02-11 |
Stevens Christopher James |
Chief Operating Officer |
Concesión de RSU |
93,037 |
$3.24 |
$301.44K |
93,037 |
| 2026-01-02 |
Bjork Elisabeth |
Director |
Compra Informativa |
10,000 |
$3.44 |
$34.4K |
50,000 |
| 2025-11-18 |
Militello John |
See Remarks |
Venta Informativa |
1,086 |
$2.98 |
$3.24K |
65,920 |
| 2025-11-18 |
Wilson Martin |
General Counsel |
Venta Informativa |
1,646 |
$2.98 |
$4.91K |
383,816 |
| 2025-11-18 |
Shah Gaurav |
CEO |
Venta Informativa |
6,276 |
$2.98 |
$18.72K |
778,296 |
| 2025-11-18 |
Schwartz Jonathan David |
See Remarks |
Venta Informativa |
2,545 |
$2.98 |
$7.59K |
299,064 |
| 2025-11-03 |
Wilson Martin |
General Counsel |
Concesión de RSU |
100,000 |
- |
- |
385,462 |
| 2025-10-14 |
Militello John |
See Remarks |
Venta Informativa |
558 |
$3.98 |
$2.22K |
67,006 |
| 2025-10-06 |
Rizvi Syed Ali-aamir |
Chief Medical Officer |
Concesión de RSU |
283,018 |
- |
- |
283,018 |
| 2025-09-24 |
Fong Peter |
Officer |
Desconocido |
- |
- |
- |
- |
| 2025-09-24 |
Fong Peter |
Director |
Concesión de RSU |
23,333 |
- |
- |
23,333 |
| 2025-09-19 |
Rtw Investments, Lp |
10 Percent Owner, Other: See Remarks |
Ejercicio de Opciones (ITM) |
1 |
$17.81 |
$17.81 |
- |
| 2025-09-15 |
Rizvi Syed Ali-aamir |
Officer |
Desconocido |
- |
- |
- |
- |
| 2025-09-08 |
Militello John |
See Remarks |
Concesión de RSU |
40,000 |
- |
- |
95,924 |
| 2025-09-08 |
Wilson Martin |
General Counsel |
Concesión de RSU |
150,000 |
- |
- |
285,462 |
| 2025-09-08 |
Schwartz Jonathan David |
See Remarks |
Concesión de RSU |
80,000 |
- |
- |
301,609 |
| 2025-08-27 |
Bjork Elisabeth |
Director |
Compra Informativa |
10,000 |
$3.41 |
$34.1K |
40,000 |
| 2025-08-19 |
Militello John |
See Remarks |
Venta Informativa |
361 |
$3.00 |
$1.08K |
55,924 |
| 2025-08-19 |
Wilson Martin |
General Counsel |
Venta Informativa |
588 |
$3.00 |
$1.76K |
135,462 |
| 2025-08-19 |
Schwartz Jonathan David |
See Remarks |
Venta Informativa |
805 |
$3.00 |
$2.41K |
221,609 |
| 2025-08-18 |
Militello John |
See Remarks |
Venta Informativa |
699 |
$3.07 |
$2.14K |
56,285 |
| 2025-08-18 |
Wilson Martin |
General Counsel |
Venta Informativa |
1,004 |
$3.07 |
$3.08K |
136,050 |
| 2025-08-18 |
Shah Gaurav |
CEO |
Retención Fiscal de RSU |
2,234 |
$3.05 |
$6.81K |
784,572 |
| 2025-08-18 |
Schwartz Jonathan David |
See Remarks |
Venta Informativa |
1,680 |
$3.07 |
$5.15K |
222,414 |
| 2025-08-14 |
Militello John |
See Remarks |
Venta Informativa |
7,043 |
$3.02 |
$21.26K |
56,984 |
| 2025-08-14 |
Wilson Martin |
General Counsel |
Venta Informativa |
12,109 |
$3.02 |
$36.56K |
137,054 |
| 2025-08-14 |
Schwartz Jonathan David |
See Remarks |
Venta Informativa |
11,161 |
$3.02 |
$33.7K |
224,094 |
| 2025-08-04 |
Stevens Christopher James |
Chief Operating Officer |
Concesión de RSU |
407,166 |
- |
- |
407,166 |
| 2025-07-07 |
Stevens Christopher James |
Officer |
Desconocido |
- |
- |
- |
- |
| 2025-07-03 |
Ondrey Aaron |
Chief Financial Officer |
Venta Informativa |
1,477 |
$2.88 |
$4.26K |
128,173 |
| 2025-06-18 |
Granadillo Pedro P |
Director |
Concesión de RSU |
30,000 |
- |
- |
30,000 |
| 2025-06-18 |
Southwell David P |
Director |
Concesión de RSU |
30,000 |
- |
- |
31,660 |
| 2025-06-18 |
Boess Carsten |
Director |
Concesión de RSU |
30,000 |
- |
- |
30,000 |
| 2025-06-18 |
Dolsten Mikael |
Director |
Concesión de RSU |
30,000 |
- |
- |
44,220 |
| 2025-06-18 |
Wong Roderick |
10 Percent Owner |
Concesión de RSU |
30,000 |
- |
- |
30,000 |
| 2025-06-18 |
Malik Fady Ibraham |
Director |
Concesión de RSU |
30,000 |
- |
- |
30,000 |
| 2025-06-18 |
Makker Gotham |
Director |
Concesión de RSU |
30,000 |
- |
- |
395,912 |
| 2025-06-18 |
Bjork Elisabeth |
Director |
Concesión de RSU |
30,000 |
- |
- |
30,000 |
| 2025-06-18 |
Pratumsuwan Piratip |
Director |
Concesión de RSU |
30,000 |
- |
- |
30,000 |
■ Informativa — transacción en mercado abierto (más significativa)
■ No informativa (compra) — premio, ejercicio de opción, conversión
■ No informativa (venta) — retención fiscal, venta de adjudicación
■ Neutral — regalo, fideicomiso, vencimiento
